Leveraging Process Analytical Technologies (PAT) for Drug Manufacturing Excellence, a New Webcast, to Air on September 12th at 11 AM (EST)

Share Article

Dr. Pankaj Mohan, Process Engineering Director at Genentech, will outline best practices and offer real-world examples of how to use Six Sigma's "DMAIC" as a framework for pharmaceutical PAT implementations. GE Fanuc's Life Sciences manager Bart Reitter will discuss some of pharma PAT's most challenging data integration issues. Pharmaceutical Manufacturing editor in chief, Agnes Shanley, will provide a brief overview of issues, trends and "transformational leaders" driving pharmaceutical PAT within their organizations. Tune in on September 12 at 11 a.m. EST.

Ever since the U.S. Food and Drug Administration (FDA) endorsed the use of process analytical technologies (PAT), there has been a growing interest in applying PAT to improve drug development and manufacturing.

But, as the number of PAT conferences increases dramatically, so does the hype surrounding the term. Some may view PAT as "technologies," rather than a set of tools that can help drug companies improve operational efficiency and achieve Quality by Design.

As a result, the direct connection between PAT and Operational Excellence principles, and programs such as Lean, Six Sigma, or OEE, is lost. And so is discussion of the data integration challenges involved in any PAT implementation in the drug industry.

On September 12, 2006 (at 11 a.m. EST), process engineering expert Dr. Pankaj Mohan will discuss how pharmaceutical manufacturing and operations specialists can apply PAT, not as an end in itself, but as a tool to help achieve general manufacturing excellence.

As Dr. Mohan, process engineering director at Genentech and author of the recent book "Pharmaceutical Operations Management - Manufacturing for Competitive Advantage" explains, using Six Sigma's "DMAIC" framwork can lead to successful PAT implementation and enhance general manufacturing excellence.

Bart Reitter, Life Sciences manager at GE Fanuc, will discuss some of the data integration issues that can make pharmaceutical PAT projects particularly challenging, and how to address them.

Agnes Shanley, editor of Pharmaceutical Manufacturing magazine, PharmaManufacturing.com, and PAT Insider, will moderate the Q&A,and start the program with a brief overview of current issues and trends, and point to some of the "transformational leaders" who are driving successful pharma PAT programs.

The program is sponsored by GE Fanuc. For more information, or to register, please visit PharmaManufacturing.com, and click on http://www.pharmamanufacturing.com/webcasts/pat/leveraging_pat_achieve_op_ex.html

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Agnes Shanley
Visit website